转导管大动脉植入的发展指示:从程序性挑战到终身管理的关键问题
Pasquale Paolisso1, Davide Ausiello1, Francesco Cefalì1
1Cardiology Unit, Sant'Andrea University Hospital, Rome, Italy.
The Canadian journal of cardiology
|December 13, 2025
概括
过导管大动脉植入 (TAVI) 现在是严重的大动脉狭窄的第一线治疗方法. 终身门管理,考虑到假肢耐用性和患者因素,对于最佳的长期结果至关重要.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 人造心脏门是一种假心脏门.
背景情况:
- 过导管大动脉植入 (TAVI) 已经从治疗无法手术的患者发展成为所有风险组中严重大动脉狭窄的第一线治疗.
- 扩大TAVI的指示包括年轻,低风险和无症状的患者,需要转向终身门管理.
- 关键考虑因素包括优化初始程序,同时规划长期结果,如假肢耐用性和重新干预.
研究的目的:
- 审查跨导管大动脉植入 (TAVI) 的不断变化的景观.
- 在终身门管理的背景下,讨论优化患者结果的挑战和策略.
- 突出设备选择,程序规划和药理疗法的重要性.
主要方法:
- 关于TAVI的当前文献和临床实践指南的审查.
- 解剖学因素 (双主动脉,小) 的分析及其对TAVI结果的影响.
- 评估长期考虑因素,包括假肢耐用性,重新干预 (TAVI-in-TAVI) 和传导干扰的管理.
主要成果:
- 新一代设备和精细的规划已经改善了结果,尽管像双主动脉这样的解剖学挑战.
- TAVI-in-TAVI是一种可行的再干预策略,但冠状动脉再接入和患者假肢不匹配的挑战仍然存在.
- 导电障碍和心脏起器植入仍然很常见,强调技术和节奏策略.
结论:
- 实现TAVI的持久,有利的结果需要综合整合解剖学和临床因素的综合方法.
- 个性化设备选择,终身规划和药理疗法的优化对于治疗TAVI患者的管理至关重要.
- 范式的转变需要平衡即时的程序成功与长期的门性能和患者福祉.
更多相关视频
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
12.2K
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
3.3K
相关概念视频
01:22Mitral Valve Prolapse II: Assessment and Management
380
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
380
01:26Mitral Stenosis III: Medical Management
220
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
01:25Aortic Regurgitation III: Medical Management
373
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
373
01:18Endocarditis III: Medical Management
197
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
197
01:27Mitral Stenosis IV: Nursing Management
234
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
234
01:19Mitral Valve Prolapse III: Nursing Management
262
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
262